Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients

Chengkai Yang1 The Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, 350025, People’s Republic of ChinaView further author information

Xiaoya Wu2 Eastern Hospital Affiliated to Xiamen University, Fuzhou, 350025, People’s Republic of ChinaView further author information

Jianyong Liu3 Department of Hepatobiliary Surgery, 900 Hospital of The Joint Logistics Team, Fuzhou, 350025, People’s Republic of ChinaView further author information

Huaxiang Wang1 The Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, 350025, People’s Republic of ChinaView further author information

Yi Jiang3 Department of Hepatobiliary Surgery, 900 Hospital of The Joint Logistics Team, Fuzhou, 350025, People’s Republic of ChinaView further author information

Zhihong Wei3 Department of Hepatobiliary Surgery, 900 Hospital of The Joint Logistics Team, Fuzhou, 350025, People’s Republic of ChinaView further author information

Qiucheng Cai3 Department of Hepatobiliary Surgery, 900 Hospital of The Joint Logistics Team, Fuzhou, 350025, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

show all

Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients

Citations (1)

Read on this site (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date